| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID12680 |
| PMID | 25168216 |
| Peptide Sequence | SLAELGGHLDQQVEEF |
| Peptide Sequence in Publication | SLAELGGHLDQQVEEF |
| Protein Name | Apolipoprotein A-IV |
| UniprotKB Entry Name | APOA4_HUMAN |
| Biofluid | Serum |
| M/Z | NA |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | 1771.8 |
| Profiling Technique | LC-MS |
| Peptide Identification Technique | LC-MS/MS |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | 4.80E_05 |
| Software | MASCOT |
| Length of Peptide | 16 |
| Cancer Type | Renal cell carcinaoma |
| Database for Peptide search | SwissProt Database |
| Modification | NA |
| Number of Patients | "30 RCC patients and 30 healthy controls for training dataset and 6 RCC patients, 6 control in independent validation dataset" |
| Regulation/Differential Expression | Upregulated in cancer v/s Normal |
| Validation | Independent validation |
| Sensitivity | 100 % (for 19 peptide signatures) |
| Specificity | NA |
| Accuracy | AUC : 0.850 |
| Secondary information |
|---|
| Peptide Atlas | PeptideAtlas |
| IEDB | |